| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | WO2002000710A3 B7-like molecules and uses thereof |
| 09/26/2002 | WO2001098332A3 Secreted redox proteins |
| 09/26/2002 | WO2001095711A3 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 09/26/2002 | WO2001094600A3 Promoters for regulated gene expression |
| 09/26/2002 | WO2001092465A8 Maize glutamine synthetase gene promoter |
| 09/26/2002 | WO2001090159B1 Compositions and methods for delivery of a molecule into a cell |
| 09/26/2002 | WO2001083775A3 Proteases |
| 09/26/2002 | WO2001073002A3 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 09/26/2002 | WO2001047953A3 Antibodies against plasma cells |
| 09/26/2002 | WO2001025401A9 A mycobacterium tuberculosis coding sequence for expression of heterologous proteins |
| 09/26/2002 | WO2001023421A9 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
| 09/26/2002 | WO2001020012A9 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 09/26/2002 | WO2001019977A9 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 09/26/2002 | WO2001019861A9 Apo-2 receptor antibodies |
| 09/26/2002 | WO2001016295A9 Novel natriuretic peptide receptors, interacting compounds and methods of regulating proliferation and/or survival of neurons |
| 09/26/2002 | WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use |
| 09/26/2002 | US20020138876 Transformed plant cells and plants regenerated from these cells, which exhibit an increase or reduced activity of starch synthases; genetic engineering |
| 09/26/2002 | US20020138874 Elongase genes and uses thereof |
| 09/26/2002 | US20020138872 Transgenic plants; enhanced defense mechanisms to combat plant diseases; disease resistant plants |
| 09/26/2002 | US20020138870 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 09/26/2002 | US20020138865 In vitro transfection, storage and transfer of male germ cells for generation of transgenic species & genetic therapies |
| 09/26/2002 | US20020138864 Electroporating a foreign gene into avian primordial germ cells after addition of dimethyl sulfoxide to culture medium containing the cells |
| 09/26/2002 | US20020138862 Mice show an increased insulin sensitivity, and resistance to weight gain compared to wild-type mice on same diet; screening for enzyme inhibitors; antiobesity, antidiabetic agents |
| 09/26/2002 | US20020138859 Nucleic acid sequences; use of such enzymes to produce taxanes |
| 09/26/2002 | US20020138857 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 09/26/2002 | US20020137915 Conformational and topological protein regulation |
| 09/26/2002 | US20020137909 Designated as "PRO19598" polypeptides; diagnosis and treatment of tumors |
| 09/26/2002 | US20020137894 Megakaryocyte stimulating factors |
| 09/26/2002 | US20020137886 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/26/2002 | US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 09/26/2002 | US20020137679 Thrombospondins-1 and -2 are adhesive glycoproteins proteins that are angiogenesis inhibitors; portions of TSP- 1, TSP-2, endostatin, angiostatin, platelet factor 4, or prolactin linked to a portion of cartilage oligoeric matrix protein |
| 09/26/2002 | US20020137677 Soluble zalpha11 cytokine receptors |
| 09/26/2002 | US20020137208 Method for microproduction of tea plants from leaf explants |
| 09/26/2002 | US20020137207 Cultured cells of Rhapiolepis umbellata thunb. and a method for culturing tissues of the Rhapiolepis umbellata thunb. by using said cultured cells |
| 09/26/2002 | US20020137206 Subculturing a cultured undifferentiated cell in a medium containing thidiazuron |
| 09/26/2002 | US20020137204 Conditioned medium collected from a culture of feeder cells with laminin or collagen |
| 09/26/2002 | US20020137202 Diagnosis, treatment, and prevention of disorders associated with a FCTRX nucleic acid, polypeptide, or an antibody specific for it |
| 09/26/2002 | US20020137189 Cardiac hypertrophy factor and uses therefor |
| 09/26/2002 | US20020137184 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and use thereof |
| 09/26/2002 | US20020137182 For obtaining and using a polypeptide other than oncogene BCL-2 that affects programmed vertebrate cell death |
| 09/26/2002 | US20020137166 ASIP-related proteins |
| 09/26/2002 | US20020137145 Human erythropoietin gene: high level expression in stably transfected mammalian cells |
| 09/26/2002 | US20020137142 Tango-73 nucleic acids |
| 09/26/2002 | US20020137138 Modulating serotonin activity |
| 09/26/2002 | US20020137137 Genetic engineering; polypeptides |
| 09/26/2002 | US20020137134 Genetic engineering; glycoproteins |
| 09/26/2002 | US20020137133 Receptor proteins |
| 09/26/2002 | US20020137129 Polypeptides; genetic engineering; drug development |
| 09/26/2002 | US20020137127 Culture product; polypeptides |
| 09/26/2002 | US20020137115 Cgmp- visualizing probe and a method of detecting and quantifying of cgmp by using the same |
| 09/26/2002 | US20020137109 Anticarcinogenic agents;monitoring therapy efficiency |
| 09/26/2002 | US20020137095 Reelin protein CR-50 epitope region |
| 09/26/2002 | US20020137094 Method for improving thermostability of proteins, proteins having thermostability improved by the method and nucleic acids encoding the proteins |
| 09/26/2002 | US20020137049 Pablo, a polypeptide that interacts with Bcl-xL, and uses related thereto |
| 09/26/2002 | US20020137038 Intestinal proteins |
| 09/26/2002 | US20020137028 Use of neuronal apoptosis inhibitor protein (naip) |
| 09/26/2002 | US20020137018 Screening for antitumor agents |
| 09/26/2002 | US20020136754 Recombinant bacterial phytases and uses thereof |
| 09/26/2002 | US20020136730 From coagulase-negative bacteria produced in substantially pure form; use of purified adhesin product as vaccine for production of antibodies effective against binding of homologous bacterial cells to polymeric materials |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136717 Process for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1 binding domain or a protein having an EVH1 binding domain, and a process for detecting said interaction |
| 09/26/2002 | US20020136709 Producing human pluripotent stem cells from human adult somatic cells by treating adult somatic cells with agent that promotes cellular reprogramming |
| 09/26/2002 | US20020136705 Porcine spinal cord cells and their use in spinal cord repair |
| 09/26/2002 | CA2852293A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2460779A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells |
| 09/26/2002 | CA2441902A1 Chimpanzee erythropoietin (chepo) - immunoadhesins |
| 09/26/2002 | CA2441740A1 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | CA2441571A1 Methods for identifying and purifying smooth muscle progenitor cells |
| 09/26/2002 | CA2441564A1 Production of pancreatic islet cells and delivery of insulin |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441289A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 09/26/2002 | CA2441057A1 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 09/26/2002 | CA2440966A1 Characterization of the i-spomi endonuclease from fission yeast |
| 09/26/2002 | CA2440960A1 An early pre-symptomatic prion diagnostic blood test for encephalopathies |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2438483A1 Histidine phosphatase interacting protein with 240kd |
| 09/26/2002 | CA2438315A1 Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
| 09/26/2002 | CA2435664A1 Ncc2705-the genome of a bifidobacterium |
| 09/25/2002 | EP1243655A1 Modified HPV E6 and E7 genes and proteins useful for vaccination |
| 09/25/2002 | EP1243654A1 Precursor polypeptides of phytosulfokine derived from Arabidopsis thaliana and cDNAs encoding said polypeptides |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1243597A2 Receptors for human interleukin-12 |
| 09/25/2002 | EP1243596A2 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase and methods for identification of inhibitors thereof |
| 09/25/2002 | EP1242815A1 The manufacture of improved support matrices |
| 09/25/2002 | EP1242629A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 09/25/2002 | EP1242624A2 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 09/25/2002 | EP1242617A2 Method of classifying a thyroid carcinoma using differential gene expression |
| 09/25/2002 | EP1242607A1 Transgenic insect |
| 09/25/2002 | EP1242604A2 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 09/25/2002 | EP1242601A1 Trichoderma reesei xylanase |
| 09/25/2002 | EP1242600A1 Cytokine zcyto18 |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242595A1 Promoter and intron from maize actin depolymerizing factor |
| 09/25/2002 | EP1242592A2 A molecular switch for regulating mammalian gene expression |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242586A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |